| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hexokinase activity | 2.26e-06 | 5 | 10 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | glucokinase activity | 2.26e-06 | 5 | 10 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | fructokinase activity | 2.26e-06 | 5 | 10 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | D-glucose binding | 2.05e-05 | 14 | 10 | 2 | GO:0005536 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 4.72e-05 | 21 | 10 | 2 | GO:0019200 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 9.83e-04 | 95 | 10 | 2 | GO:0048029 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 4.44e-03 | 709 | 10 | 3 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 5.47e-03 | 764 | 10 | 3 | GO:0016301 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.52e-03 | 268 | 10 | 2 | GO:0005539 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 9.67e-03 | 938 | 10 | 3 | GO:0016772 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 9.96e-03 | 310 | 10 | 2 | GO:0030246 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in mitochondrion | 2.11e-06 | 5 | 10 | 2 | GO:0072656 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 2.53e-05 | 16 | 10 | 2 | GO:0006002 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 4.42e-05 | 21 | 10 | 2 | GO:0006735 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 4.42e-05 | 21 | 10 | 2 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 4.42e-05 | 21 | 10 | 2 | GO:0061718 | |
| GeneOntologyBiologicalProcess | NAD catabolic process | 6.31e-05 | 25 | 10 | 2 | GO:0019677 | |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 6.31e-05 | 25 | 10 | 2 | GO:0046835 | |
| GeneOntologyBiologicalProcess | glycolytic process through glucose-6-phosphate | 6.31e-05 | 25 | 10 | 2 | GO:0061620 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 9.76e-05 | 31 | 10 | 2 | GO:0061615 | |
| GeneOntologyBiologicalProcess | glucose 6-phosphate metabolic process | 1.04e-04 | 32 | 10 | 2 | GO:0051156 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 1.04e-04 | 32 | 10 | 2 | GO:0006007 | |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 1.32e-04 | 218 | 10 | 3 | GO:0001678 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 1.80e-04 | 42 | 10 | 2 | GO:0006734 | |
| GeneOntologyBiologicalProcess | maintenance of protein localization in organelle | 2.26e-04 | 47 | 10 | 2 | GO:0072595 | |
| GeneOntologyBiologicalProcess | hexose catabolic process | 2.88e-04 | 53 | 10 | 2 | GO:0019320 | |
| GeneOntologyBiologicalProcess | monosaccharide catabolic process | 3.33e-04 | 57 | 10 | 2 | GO:0046365 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 4.81e-04 | 338 | 10 | 3 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 4.85e-04 | 339 | 10 | 3 | GO:0033500 | |
| GeneOntologyBiologicalProcess | response to ischemia | 5.31e-04 | 72 | 10 | 2 | GO:0002931 | |
| GeneOntologyBiologicalProcess | NAD metabolic process | 5.76e-04 | 75 | 10 | 2 | GO:0019674 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in cell | 5.92e-04 | 76 | 10 | 2 | GO:0032507 | |
| GeneOntologyBiologicalProcess | glycolytic process | 1.23e-03 | 110 | 10 | 2 | GO:0006096 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 1.28e-03 | 112 | 10 | 2 | GO:0045185 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 1.32e-03 | 114 | 10 | 2 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 1.39e-03 | 117 | 10 | 2 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 1.39e-03 | 117 | 10 | 2 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 1.44e-03 | 119 | 10 | 2 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 1.47e-03 | 120 | 10 | 2 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 1.49e-03 | 121 | 10 | 2 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 1.54e-03 | 123 | 10 | 2 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 1.56e-03 | 124 | 10 | 2 | GO:0009134 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 1.60e-03 | 512 | 10 | 3 | GO:0009150 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental growth | 1.61e-03 | 126 | 10 | 2 | GO:0048640 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 1.63e-03 | 515 | 10 | 3 | GO:0072594 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 1.77e-03 | 132 | 10 | 2 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 1.77e-03 | 132 | 10 | 2 | GO:0009179 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to mitochondrion | 1.80e-03 | 133 | 10 | 2 | GO:0072655 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 1.80e-03 | 533 | 10 | 3 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 1.87e-03 | 540 | 10 | 3 | GO:0019693 | |
| GeneOntologyBiologicalProcess | protein localization to mitochondrion | 2.01e-03 | 141 | 10 | 2 | GO:0070585 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 2.04e-03 | 142 | 10 | 2 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 2.07e-03 | 143 | 10 | 2 | GO:0009185 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 2.25e-03 | 149 | 10 | 2 | GO:0009132 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 2.76e-03 | 619 | 10 | 3 | GO:0006163 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 2.88e-03 | 169 | 10 | 2 | GO:0009154 | |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 3.18e-03 | 178 | 10 | 2 | GO:0009261 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 3.20e-03 | 652 | 10 | 3 | GO:0072521 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 3.33e-03 | 182 | 10 | 2 | GO:0006195 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 3.54e-03 | 188 | 10 | 2 | GO:0072523 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 3.66e-03 | 684 | 10 | 3 | GO:0009117 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 3.77e-03 | 691 | 10 | 3 | GO:0006753 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 3.84e-03 | 196 | 10 | 2 | GO:0016052 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 4.08e-03 | 202 | 10 | 2 | GO:0019362 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 4.08e-03 | 202 | 10 | 2 | GO:0046496 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process | 4.20e-03 | 718 | 10 | 3 | GO:0043065 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 4.32e-03 | 208 | 10 | 2 | GO:0009166 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 4.40e-03 | 210 | 10 | 2 | GO:0072524 | |
| GeneOntologyBiologicalProcess | positive regulation of programmed cell death | 4.55e-03 | 739 | 10 | 3 | GO:0043068 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 4.65e-03 | 216 | 10 | 2 | GO:1901292 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 4.95e-03 | 223 | 10 | 2 | GO:0007519 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 5.05e-03 | 767 | 10 | 3 | GO:0055086 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 5.16e-03 | 228 | 10 | 2 | GO:0043393 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 5.71e-03 | 240 | 10 | 2 | GO:0060538 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 5.89e-03 | 244 | 10 | 2 | GO:0006006 | |
| Domain | Hexokinase_C | 2.58e-06 | 5 | 10 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 2.58e-06 | 5 | 10 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 2.58e-06 | 5 | 10 | 2 | PF00349 | |
| Domain | HEXOKINASE_2 | 2.58e-06 | 5 | 10 | 2 | PS51748 | |
| Domain | Hexokinase_2 | 2.58e-06 | 5 | 10 | 2 | PF03727 | |
| Domain | Hexokinase_BS | 2.58e-06 | 5 | 10 | 2 | IPR019807 | |
| Domain | HEXOKINASE_1 | 2.58e-06 | 5 | 10 | 2 | PS00378 | |
| Domain | Hexokinase | 3.87e-06 | 6 | 10 | 2 | IPR001312 | |
| Pathway | WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER | 2.91e-06 | 42 | 10 | 3 | M45531 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS | 6.78e-06 | 6 | 10 | 2 | M47654 | |
| Pathway | WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS | 2.48e-05 | 11 | 10 | 2 | M48094 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.03e-04 | 137 | 10 | 3 | M18155 | |
| Pathway | KEGG_GALACTOSE_METABOLISM | 1.46e-04 | 26 | 10 | 2 | M4377 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 2.51e-04 | 34 | 10 | 2 | M15898 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 3.48e-04 | 40 | 10 | 2 | M39595 | |
| Pathway | KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM | 4.22e-04 | 44 | 10 | 2 | M8104 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 4.41e-04 | 45 | 10 | 2 | M39474 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 4.81e-04 | 47 | 10 | 2 | M19708 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 5.67e-04 | 51 | 10 | 2 | MM15928 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.89e-04 | 52 | 10 | 2 | M14171 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 8.37e-04 | 62 | 10 | 2 | M11521 | |
| Pathway | PID_HIF1_TFPATHWAY | 9.48e-04 | 66 | 10 | 2 | M255 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.46e-03 | 82 | 10 | 2 | MM15394 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.57e-03 | 85 | 10 | 2 | M1870 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 1.60e-03 | 86 | 10 | 2 | M39375 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 1.79e-03 | 91 | 10 | 2 | M48079 | |
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 21504994 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 24990892 | ||
| Pubmed | Effect of Increased IL-1β on Expression of HK in Alzheimer's Disease. | 2.23e-07 | 3 | 10 | 2 | 33525649 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 19049977 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 26855992 | ||
| Pubmed | Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. | 2.23e-07 | 3 | 10 | 2 | 21430642 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 20347420 | ||
| Pubmed | Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2. | 2.23e-07 | 3 | 10 | 2 | 30871777 | |
| Pubmed | c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. | 2.23e-07 | 3 | 10 | 2 | 28054552 | |
| Pubmed | Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. | 4.46e-07 | 4 | 10 | 2 | 25904018 | |
| Pubmed | Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. | 4.46e-07 | 4 | 10 | 2 | 23962723 | |
| Pubmed | High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. | 4.46e-07 | 4 | 10 | 2 | 25766729 | |
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 32152094 | ||
| Pubmed | 7.44e-07 | 5 | 10 | 2 | 15574336 | ||
| Pubmed | Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. | 9.68e-07 | 71 | 10 | 3 | 23503661 | |
| Pubmed | Hepatic glycogen synthesis in the absence of glucokinase: the case of embryonic liver. | 1.56e-06 | 7 | 10 | 2 | 18165236 | |
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 19554504 | ||
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 21074528 | ||
| Pubmed | Proteomics identifies the developmental regulation of HKDC1 in liver of pigs and mice. | 3.34e-06 | 10 | 10 | 2 | 37545422 | |
| Pubmed | 2.22e-05 | 25 | 10 | 2 | 32913122 | ||
| Pubmed | Characterising the dynamics of placental glycogen stores in the mouse. | 3.01e-05 | 29 | 10 | 2 | 32798765 | |
| Pubmed | Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function. | 3.22e-05 | 30 | 10 | 2 | 27133129 | |
| Pubmed | Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. | 4.40e-05 | 35 | 10 | 2 | 19862010 | |
| Pubmed | 5.20e-05 | 38 | 10 | 2 | 20185832 | ||
| Pubmed | 9.07e-05 | 323 | 10 | 3 | 24797263 | ||
| Pubmed | A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis. | 1.02e-04 | 53 | 10 | 2 | 38466355 | |
| Pubmed | Seventy-five genetic loci influencing the human red blood cell. | 1.39e-04 | 62 | 10 | 2 | 23222517 | |
| Pubmed | 1.49e-04 | 382 | 10 | 3 | 29222160 | ||
| Pubmed | An analysis of expression patterns of genes encoding proteins with catalytic activities. | 1.63e-04 | 67 | 10 | 2 | 17626619 | |
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 1.83e-04 | 71 | 10 | 2 | 29346117 | |
| Pubmed | Multiple common variants for celiac disease influencing immune gene expression. | 2.10e-04 | 76 | 10 | 2 | 20190752 | |
| Pubmed | Regulation of MAGE-A3/6 by the CRL4-DCAF12 ubiquitin ligase and nutrient availability. | 2.88e-04 | 89 | 10 | 2 | 31267705 | |
| Interaction | HK3 interactions | 1.05e-04 | 35 | 9 | 2 | int:HK3 | |
| Interaction | SLC15A3 interactions | 1.23e-04 | 234 | 9 | 3 | int:SLC15A3 | |
| Interaction | HEPACAM2 interactions | 1.30e-04 | 39 | 9 | 2 | int:HEPACAM2 | |
| Interaction | MARCHF3 interactions | 1.59e-04 | 43 | 9 | 2 | int:MARCHF3 | |
| Interaction | NAA35 interactions | 2.51e-04 | 54 | 9 | 2 | int:NAA35 | |
| Interaction | RHOT2 interactions | 3.13e-04 | 321 | 9 | 3 | int:RHOT2 | |
| Interaction | BTN2A1 interactions | 3.31e-04 | 62 | 9 | 2 | int:BTN2A1 | |
| Interaction | MARCHF8 interactions | 3.31e-04 | 62 | 9 | 2 | int:MARCHF8 | |
| Interaction | HEXB interactions | 3.52e-04 | 64 | 9 | 2 | int:HEXB | |
| Interaction | RNF128 interactions | 3.86e-04 | 67 | 9 | 2 | int:RNF128 | |
| Interaction | ZBTB44 interactions | 3.86e-04 | 67 | 9 | 2 | int:ZBTB44 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.58e-06 | 71 | 9 | 3 | M2948 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | 9.40e-06 | 1012 | 9 | 5 | M40868 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 3.50e-05 | 199 | 9 | 3 | M9595 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN | 3.55e-05 | 200 | 9 | 3 | M3091 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN | 3.55e-05 | 200 | 9 | 3 | M9692 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP | 3.55e-05 | 200 | 9 | 3 | M4963 | |
| Coexpression | SEMENZA_HIF1_TARGETS | 6.56e-05 | 36 | 9 | 2 | M12299 | |
| Coexpression | BRUNO_HEMATOPOIESIS | 2.29e-04 | 67 | 9 | 2 | M1492 | |
| Coexpression | BRUNO_HEMATOPOIESIS | 2.72e-04 | 73 | 9 | 2 | MM645 | |
| Coexpression | HALLMARK_CHOLESTEROL_HOMEOSTASIS | 2.79e-04 | 74 | 9 | 2 | M5892 | |
| Coexpression | SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE | 3.35e-04 | 81 | 9 | 2 | M11189 | |
| Coexpression | HARRIS_HYPOXIA | 3.35e-04 | 81 | 9 | 2 | M10508 | |
| Coexpression | GUO_TARGETS_OF_IRS1_AND_IRS2 | 4.80e-04 | 97 | 9 | 2 | M2434 | |
| Coexpression | GUO_TARGETS_OF_IRS1_AND_IRS2 | 4.80e-04 | 97 | 9 | 2 | MM1318 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 5.93e-04 | 519 | 9 | 3 | M3395 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 6.77e-04 | 543 | 9 | 3 | MM997 | |
| Coexpression | QI_HYPOXIA | 8.99e-04 | 133 | 9 | 2 | M2133 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE | 9.39e-04 | 136 | 9 | 2 | M40899 | |
| Coexpression | QI_HYPOXIA | 9.95e-04 | 140 | 9 | 2 | MM1290 | |
| Coexpression | PKCA_DN.V1_DN | 1.20e-03 | 154 | 9 | 2 | M2754 | |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 1.31e-03 | 161 | 9 | 2 | M7728 | |
| Coexpression | UEDA_PERIFERAL_CLOCK | 1.48e-03 | 171 | 9 | 2 | M12498 | |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | 1.56e-03 | 724 | 9 | 3 | M41700 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | 1.56e-03 | 176 | 9 | 2 | M7725 | |
| Coexpression | UEDA_PERIFERAL_CLOCK | 1.58e-03 | 177 | 9 | 2 | MM1145 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 1.69e-03 | 183 | 9 | 2 | M7631 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 1.80e-03 | 761 | 9 | 3 | M11961 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP | 1.84e-03 | 191 | 9 | 2 | M8251 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 1.90e-03 | 776 | 9 | 3 | M1107 | |
| Coexpression | GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP | 1.92e-03 | 195 | 9 | 2 | M9873 | |
| Coexpression | GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 1.92e-03 | 195 | 9 | 2 | M5330 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.93e-03 | 196 | 9 | 2 | M5349 | |
| Coexpression | GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 1.93e-03 | 196 | 9 | 2 | M5333 | |
| Coexpression | GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP | 1.93e-03 | 196 | 9 | 2 | M5862 | |
| Coexpression | GSE17721_LPS_VS_CPG_0.5H_BMDC_UP | 1.97e-03 | 198 | 9 | 2 | M3982 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 1.97e-03 | 198 | 9 | 2 | M6123 | |
| Coexpression | GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 1.97e-03 | 198 | 9 | 2 | M5335 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP | 1.97e-03 | 198 | 9 | 2 | M8649 | |
| Coexpression | GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 1.97e-03 | 198 | 9 | 2 | M3273 | |
| Coexpression | GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP | 1.97e-03 | 198 | 9 | 2 | M5856 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP | 1.99e-03 | 199 | 9 | 2 | M3918 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP | 1.99e-03 | 199 | 9 | 2 | M5599 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP | 1.99e-03 | 199 | 9 | 2 | M4058 | |
| Coexpression | GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP | 1.99e-03 | 199 | 9 | 2 | M5716 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_UP | 1.99e-03 | 199 | 9 | 2 | M4945 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.99e-03 | 199 | 9 | 2 | M9184 | |
| Coexpression | GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.99e-03 | 199 | 9 | 2 | M9566 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.99e-03 | 199 | 9 | 2 | M9568 | |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP | 1.99e-03 | 199 | 9 | 2 | M2934 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN | 1.99e-03 | 199 | 9 | 2 | M8487 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP | 1.99e-03 | 199 | 9 | 2 | M5233 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP | 1.99e-03 | 199 | 9 | 2 | M8767 | |
| Coexpression | GSE17721_CTRL_VS_LPS_6H_BMDC_DN | 1.99e-03 | 199 | 9 | 2 | M3692 | |
| Coexpression | GSE17721_CTRL_VS_LPS_24H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3704 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP | 2.01e-03 | 200 | 9 | 2 | M9235 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3931 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3742 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP | 2.01e-03 | 200 | 9 | 2 | M9281 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | 2.01e-03 | 200 | 9 | 2 | M7489 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 2.01e-03 | 200 | 9 | 2 | M9677 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP | 2.01e-03 | 200 | 9 | 2 | M3913 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_DC_DN | 2.01e-03 | 200 | 9 | 2 | M4476 | |
| Coexpression | HALLMARK_HYPOXIA | 2.01e-03 | 200 | 9 | 2 | M5891 | |
| Coexpression | GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 2.01e-03 | 200 | 9 | 2 | M6887 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_DC_DN | 2.01e-03 | 200 | 9 | 2 | M4492 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 2.01e-03 | 200 | 9 | 2 | M7525 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 2.01e-03 | 200 | 9 | 2 | M7754 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M8847 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M7516 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN | 2.01e-03 | 200 | 9 | 2 | M6687 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP | 2.01e-03 | 200 | 9 | 2 | M5985 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN | 2.01e-03 | 200 | 9 | 2 | M9593 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M3607 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M3610 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 2.01e-03 | 200 | 9 | 2 | M8087 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M4066 | |
| Coexpression | GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M9549 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP | 2.01e-03 | 200 | 9 | 2 | M9536 | |
| Coexpression | HALLMARK_MTORC1_SIGNALING | 2.01e-03 | 200 | 9 | 2 | M5924 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M9563 | |
| Coexpression | GSE42724_NAIVE_VS_B1_BCELL_UP | 2.01e-03 | 200 | 9 | 2 | M9790 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 2.01e-03 | 200 | 9 | 2 | M6080 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP | 2.01e-03 | 200 | 9 | 2 | M8955 | |
| Coexpression | GSE17721_12H_VS_24H_CPG_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M4133 | |
| Coexpression | GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP | 2.01e-03 | 200 | 9 | 2 | M6305 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP | 2.01e-03 | 200 | 9 | 2 | M9833 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP | 2.01e-03 | 200 | 9 | 2 | M6115 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP | 2.01e-03 | 200 | 9 | 2 | M9614 | |
| Coexpression | GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP | 2.01e-03 | 200 | 9 | 2 | M6586 | |
| Coexpression | GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 2.01e-03 | 200 | 9 | 2 | M9619 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M4775 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 2.03e-03 | 794 | 9 | 3 | MM982 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.52e-03 | 856 | 9 | 3 | M4500 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 2.95e-03 | 243 | 9 | 2 | M14072 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 2.99e-03 | 909 | 9 | 3 | M41018 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | 3.30e-03 | 942 | 9 | 3 | M8144 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.67e-05 | 164 | 9 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.82e-04 | 281 | 9 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.87e-04 | 284 | 9 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.15e-04 | 799 | 9 | 4 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 2.66e-04 | 844 | 9 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.44e-04 | 349 | 9 | 3 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.82e-04 | 362 | 9 | 3 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.34e-04 | 378 | 9 | 3 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 4.55e-04 | 384 | 9 | 3 | GSM605820_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.12e-03 | 524 | 9 | 3 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-06 | 184 | 10 | 3 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Unfolded_protein_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.22e-04 | 101 | 10 | 2 | ae650e96b93a0d2f0a19ffaf37f21f02fb20651d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.38e-04 | 142 | 10 | 2 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 4.75e-04 | 148 | 10 | 2 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-04 | 166 | 10 | 2 | a2ce44702a0cd5fa5872cac3302d3c451205feef | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 5.97e-04 | 166 | 10 | 2 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-04 | 166 | 10 | 2 | 0f641302a6b71c4badaaf20f51162bfc2386b167 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-04 | 172 | 10 | 2 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-04 | 172 | 10 | 2 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 6.48e-04 | 173 | 10 | 2 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-04 | 173 | 10 | 2 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.71e-04 | 176 | 10 | 2 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 6.78e-04 | 177 | 10 | 2 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | RSV-Healthy-4|RSV / Virus stimulation, Condition and Cluster | 6.86e-04 | 178 | 10 | 2 | a5835951492c051443f3c30d45f9a7b1b2557477 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 6.86e-04 | 178 | 10 | 2 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | RSV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 6.86e-04 | 178 | 10 | 2 | a6d71aebb5c462311f8ade24f659642b6b329633 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-04 | 179 | 10 | 2 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | a0faed4cf23f6d5e6e8f6b0284cea8a5bd0680a0 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 7.01e-04 | 180 | 10 | 2 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.09e-04 | 181 | 10 | 2 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.09e-04 | 181 | 10 | 2 | 2a1aa4a0ec7bc367857beaff543135e4345c835b | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 7.25e-04 | 183 | 10 | 2 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 7.25e-04 | 183 | 10 | 2 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-04 | 185 | 10 | 2 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-04 | 185 | 10 | 2 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | facs-BAT-Fat-24m-Epithelial-Epcam+|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | b18d7398279a2d42414318aeb70514fd402f5a0a | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | 32d30f08b20a0a28e38b37bd52ab26d1d43736ce | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.56e-04 | 187 | 10 | 2 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 188 | 10 | 2 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 188 | 10 | 2 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 188 | 10 | 2 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 7.65e-04 | 188 | 10 | 2 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 188 | 10 | 2 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.73e-04 | 189 | 10 | 2 | c502f0cf16fac9f09891d288dcf0149b9eee9d10 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.89e-04 | 191 | 10 | 2 | a143af67fc3270439f390edec599d2e3d29a107f | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.89e-04 | 191 | 10 | 2 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.89e-04 | 191 | 10 | 2 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-04 | 193 | 10 | 2 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.05e-04 | 193 | 10 | 2 | 1fdfe08b0c82248545c29b504ac259b093fde29b | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.05e-04 | 193 | 10 | 2 | 5f90e3e526032d82d9dc7e0813fe79ca28dc0719 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-04 | 193 | 10 | 2 | 241a60d1f0d5832638fb3e1e4b7afa7387ea3c75 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-04 | 194 | 10 | 2 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | c48de3b9c281345c8f65427703837dd921b01826 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-04 | 194 | 10 | 2 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-04 | 195 | 10 | 2 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-04 | 195 | 10 | 2 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-04 | 195 | 10 | 2 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-04 | 195 | 10 | 2 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.30e-04 | 196 | 10 | 2 | 9ae9cf69079b8a786e775c3db5cd4c593513f698 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-04 | 196 | 10 | 2 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-04 | 196 | 10 | 2 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-PNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.47e-04 | 198 | 10 | 2 | 6408653e956fedb284fa5e69ba8f4d620731f556 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.47e-04 | 198 | 10 | 2 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | CD8+_Memory_T_cell-RSV-4|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.47e-04 | 198 | 10 | 2 | d6ee79dbb6147be09e9c7fe4e86477182571ef4c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.56e-04 | 199 | 10 | 2 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | CD8+_Memory_T_cell-FLU-4|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.56e-04 | 199 | 10 | 2 | 67ffb50490ed3fa9d2fe08fe9f864eb333f31d92 | |
| ToppCell | 10x5'v1|World / cell types per 3 fetal stages;per 3',per 5' | 8.56e-04 | 199 | 10 | 2 | 3c5d5cc0d118abad4484c5aecd43ca3116abe0a8 | |
| ToppCell | 10x5'v1-week_14-16|World / cell types per 3 fetal stages;per 3',per 5' | 8.56e-04 | 199 | 10 | 2 | 9537754bdaeba557bf8b304374082bcfbf28f40f | |
| ToppCell | FLU-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 8.56e-04 | 199 | 10 | 2 | 40061131e35131873192ca65c0e731a7b3045636 | |
| ToppCell | CD8+_Memory_T_cell-FLU|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.56e-04 | 199 | 10 | 2 | 5d2045074560ec429a9f13f1a3f866ef18884f13 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.64e-04 | 200 | 10 | 2 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| Drug | N-bromoacetylglucosamine | 1.04e-06 | 4 | 10 | 2 | CID000152920 | |
| Drug | 2,3-anhydro-D-allose | 1.04e-06 | 4 | 10 | 2 | CID000191595 | |
| Drug | AC1L5VHN | 1.04e-06 | 4 | 10 | 2 | CID000235938 | |
| Drug | 1,5-anhydroglucitol 6-phosphate | 1.04e-06 | 4 | 10 | 2 | CID003081444 | |
| Drug | 1-deoxy-D-manno-heptulose | 1.04e-06 | 4 | 10 | 2 | CID000193198 | |
| Drug | lofenal | 1.04e-06 | 4 | 10 | 2 | CID000159256 | |
| Drug | 3-chloromethylthiochromone-1,1-dioxide | 1.74e-06 | 5 | 10 | 2 | CID000100620 | |
| Drug | 2-fluoro-2-deoxy-6-phosphogluconate | 1.74e-06 | 5 | 10 | 2 | CID000127270 | |
| Drug | 8-thiocyano-ATP | 2.60e-06 | 6 | 10 | 2 | CID000132196 | |
| Drug | AC1L5A5F | 3.64e-06 | 7 | 10 | 2 | CID000173497 | |
| Drug | glucose 6-arsenate | 3.64e-06 | 7 | 10 | 2 | CID000128033 | |
| Drug | AFDG | 4.85e-06 | 8 | 10 | 2 | CID000164297 | |
| Drug | tetrahydropyran-2-methanol | 4.85e-06 | 8 | 10 | 2 | CID000007524 | |
| Drug | AC1L3THY | 6.24e-06 | 9 | 10 | 2 | CID000121839 | |
| Drug | ATP-EDC | 7.80e-06 | 10 | 10 | 2 | CID000195647 | |
| Drug | first rate | 9.53e-06 | 11 | 10 | 2 | CID000086453 | |
| Drug | triethyltin bromide | 1.35e-05 | 13 | 10 | 2 | CID000017701 | |
| Drug | acetoacetate | 1.75e-05 | 122 | 10 | 3 | CID000000096 | |
| Drug | AC1Q6HGX | 1.82e-05 | 15 | 10 | 2 | CID000000600 | |
| Drug | acadesine | 1.93e-05 | 126 | 10 | 3 | CID000017513 | |
| Drug | galactosone | 2.08e-05 | 16 | 10 | 2 | CID000097398 | |
| Drug | morpholine-citrate | 2.65e-05 | 18 | 10 | 2 | CID000173845 | |
| Drug | bromopyruvate | 2.65e-05 | 18 | 10 | 2 | ctd:C017092 | |
| Drug | I b G | 2.65e-05 | 18 | 10 | 2 | CID000447108 | |
| Drug | o-toluidine | 3.28e-05 | 20 | 10 | 2 | CID000007242 | |
| Drug | NSC 226836 | 3.28e-05 | 20 | 10 | 2 | CID000012600 | |
| Drug | 2-deoxy-D-glucose 6-phosphate | 3.63e-05 | 21 | 10 | 2 | CID000440992 | |
| Drug | cholesteryl hemisuccinate | 3.99e-05 | 22 | 10 | 2 | CID000065082 | |
| Drug | CP094 | 4.32e-05 | 165 | 10 | 3 | CID000086322 | |
| Drug | m189 | 5.42e-05 | 178 | 10 | 3 | CID000022230 | |
| Drug | 2-deoxy-2-fluoro-D-talose | 5.61e-05 | 26 | 10 | 2 | CID000068614 | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.17e-05 | 186 | 10 | 3 | 5000_DN | |
| Drug | ATP beta S | 7.00e-05 | 29 | 10 | 2 | CID000123766 | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 7.10e-05 | 195 | 10 | 3 | 866_UP | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.21e-05 | 196 | 10 | 3 | 2056_DN | |
| Drug | mg U | 7.50e-05 | 30 | 10 | 2 | CID000445508 | |
| Drug | 2,5-anhydro-D-mannitol | 8.02e-05 | 31 | 10 | 2 | CID000001494 | |
| Drug | acetylphenylhydrazine | 8.02e-05 | 31 | 10 | 2 | CID000008247 | |
| Drug | AP2PL | 8.02e-05 | 31 | 10 | 2 | CID000121867 | |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 8.98e-05 | 211 | 10 | 3 | ctd:C009618 | |
| Drug | 3-OMG | 9.10e-05 | 33 | 10 | 2 | CID000097217 | |
| Drug | bromoacetic acid | 9.10e-05 | 33 | 10 | 2 | CID000006226 | |
| Drug | lonidamine | 9.10e-05 | 33 | 10 | 2 | CID000039562 | |
| Drug | 2-deoxy-D-arabino-hexose 6-phosphate | 9.67e-05 | 34 | 10 | 2 | CID000108108 | |
| Drug | riboxin | 1.09e-04 | 36 | 10 | 2 | CID000006831 | |
| Drug | Adenosine-5'-Diphosphate | 1.09e-04 | 36 | 10 | 2 | DB03431 | |
| Drug | glycerol-3-phosphate | 1.10e-04 | 226 | 10 | 3 | CID000000754 | |
| Drug | 3-phenyllactic acid | 1.28e-04 | 39 | 10 | 2 | CID000003848 | |
| Drug | AC1L1IM7 | 1.78e-04 | 46 | 10 | 2 | CID000004638 | |
| Drug | AC1Q6RZL | 1.86e-04 | 47 | 10 | 2 | CID000001144 | |
| Drug | CID5288005 | 1.94e-04 | 48 | 10 | 2 | CID005288004 | |
| Drug | Zinc Sulfate | 1.98e-04 | 739 | 10 | 4 | ctd:D019287 | |
| Drug | glucitol-6-phosphate | 2.02e-04 | 49 | 10 | 2 | CID000000618 | |
| Drug | fluoride | 2.03e-04 | 278 | 10 | 3 | CID000014917 | |
| Drug | FT T | 2.19e-04 | 51 | 10 | 2 | CID000445622 | |
| Drug | 3-bromopyruvate | 2.28e-04 | 52 | 10 | 2 | CID000070684 | |
| Drug | AC1L494B | 2.36e-04 | 53 | 10 | 2 | CID000181487 | |
| Drug | Phenylpropanolamine | 2.36e-04 | 53 | 10 | 2 | ctd:D010665 | |
| Drug | 18F-FDG | 2.36e-04 | 53 | 10 | 2 | CID000315411 | |
| Drug | AC1L1DKE | 2.55e-04 | 55 | 10 | 2 | CID000002388 | |
| Drug | DB07744 | 2.55e-04 | 55 | 10 | 2 | CID011840941 | |
| Drug | Ptpc | 2.55e-04 | 55 | 10 | 2 | CID003036276 | |
| Drug | isoquercitrin | 2.74e-04 | 57 | 10 | 2 | ctd:C016527 | |
| Drug | AC1Q6RZ6 | 3.03e-04 | 60 | 10 | 2 | CID000000609 | |
| Drug | [(2S)-2-[(Z)-dodec-9-enoyl]oxy-3-tetradecanoyloxypropyl] [(2R,3R,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl] phosphate | 3.03e-04 | 60 | 10 | 2 | CID011968289 | |
| Drug | AC1O4QJG | 3.03e-04 | 60 | 10 | 2 | CID006398504 | |
| Drug | 2-ethoxyethanol | 3.13e-04 | 61 | 10 | 2 | ctd:C021296 | |
| Drug | AC1Q6S1V | 3.34e-04 | 63 | 10 | 2 | CID000000620 | |
| Drug | 1,6-di-o-phosphonohexopyranose | 3.45e-04 | 64 | 10 | 2 | CID000000737 | |
| Drug | dimethyl suberimidate | 3.89e-04 | 68 | 10 | 2 | CID000034750 | |
| Drug | AC1L19C4 | 4.01e-04 | 69 | 10 | 2 | CID000000483 | |
| Drug | Corn Oil | 4.01e-04 | 69 | 10 | 2 | ctd:D003314 | |
| Drug | 3-O-methyl-D-glucose | 4.37e-04 | 72 | 10 | 2 | CID000008973 | |
| Drug | 3'-AMP | 4.37e-04 | 72 | 10 | 2 | CID000041211 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 3.89e-05 | 28 | 10 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | free cholesterol in large LDL measurement | 1.31e-04 | 51 | 10 | 2 | EFO_0022176 | |
| Disease | phospholipids in IDL measurement | 1.36e-04 | 52 | 10 | 2 | EFO_0022164 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.63e-04 | 57 | 10 | 2 | EFO_0022284 | |
| Disease | cholesterol in IDL measurement | 1.69e-04 | 58 | 10 | 2 | EFO_0021899 | |
| Disease | total lipids in IDL | 1.81e-04 | 60 | 10 | 2 | EFO_0022161 | |
| Disease | free cholesterol in IDL measurement | 1.87e-04 | 61 | 10 | 2 | EFO_0022181 | |
| Disease | psoriasis, type 2 diabetes mellitus | 2.83e-04 | 75 | 10 | 2 | EFO_0000676, MONDO_0005148 | |
| Disease | intermediate density lipoprotein measurement | 3.81e-04 | 87 | 10 | 2 | EFO_0008595 | |
| Disease | lipid measurement, lipoprotein measurement | 4.07e-04 | 90 | 10 | 2 | EFO_0004529, EFO_0004732 | |
| Disease | obesity (is_implicated_in) | 4.17e-04 | 91 | 10 | 2 | DOID:9970 (is_implicated_in) | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 4.44e-04 | 94 | 10 | 2 | EFO_0008595, EFO_0010351 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 4.63e-04 | 96 | 10 | 2 | EFO_0004529, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 4.93e-04 | 99 | 10 | 2 | EFO_0004639, EFO_0008595 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 4.93e-04 | 99 | 10 | 2 | EFO_0004574, EFO_0008595 | |
| Disease | coronary artery disease (is_implicated_in) | 5.03e-04 | 100 | 10 | 2 | DOID:3393 (is_implicated_in) | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 5.44e-04 | 104 | 10 | 2 | EFO_0008591, EFO_0008595 | |
| Disease | remnant cholesterol measurement | 5.86e-04 | 108 | 10 | 2 | EFO_0010815 | |
| Disease | free cholesterol measurement | 6.41e-04 | 113 | 10 | 2 | EFO_0008591 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 6.52e-04 | 114 | 10 | 2 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 6.52e-04 | 114 | 10 | 2 | EFO_0004574, EFO_0004611 | |
| Disease | lymphocyte measurement | 6.87e-04 | 117 | 10 | 2 | EFO_0803546 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 7.23e-04 | 120 | 10 | 2 | EFO_0004611, EFO_0004639 | |
| Disease | cortical surface area measurement | 7.23e-04 | 1345 | 10 | 4 | EFO_0010736 | |
| Disease | asthma, Eczema, allergic rhinitis | 7.35e-04 | 121 | 10 | 2 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | celiac disease | 7.96e-04 | 126 | 10 | 2 | EFO_0001060 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 7.96e-04 | 126 | 10 | 2 | EFO_0004611, EFO_0010351 | |
| Disease | esterified cholesterol measurement | 8.21e-04 | 128 | 10 | 2 | EFO_0008589 | |
| Disease | polyunsaturated fatty acid measurement | 8.60e-04 | 131 | 10 | 2 | EFO_0010733 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 9.40e-04 | 137 | 10 | 2 | EFO_0004611, EFO_0008591 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.04e-03 | 144 | 10 | 2 | EFO_0004611, EFO_0020943 | |
| Disease | stroke | 1.04e-03 | 144 | 10 | 2 | EFO_0000712 | |
| Disease | obesity (biomarker_via_orthology) | 1.08e-03 | 147 | 10 | 2 | DOID:9970 (biomarker_via_orthology) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.12e-03 | 150 | 10 | 2 | EFO_0004611, EFO_0020947 | |
| Disease | apolipoprotein B measurement | 1.20e-03 | 663 | 10 | 3 | EFO_0004615 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.46e-03 | 171 | 10 | 2 | DOID:9352 (is_implicated_in) | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.48e-03 | 713 | 10 | 3 | EFO_0005689 | |
| Disease | Myocardial Ischemia | 1.54e-03 | 176 | 10 | 2 | C0151744 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVGTVTLTICMMSMN | 21 | P04035 | |
| MRMVHILTSVVGSKC | 266 | Q99700 | |
| VVAVVNDTVGTMMTC | 651 | P52789 | |
| VVAVVNDTVGTMMTC | 651 | P19367 | |
| ENKTSSVIMGVMLVC | 191 | Q8NGA5 | |
| QKVMCVSMGSTTVRV | 611 | P10586 | |
| KITENIGCVMTGMTA | 71 | P60900 | |
| MVKTSVESVGTMRAT | 326 | Q13188 | |
| SGQKTVDCMTTMSVP | 136 | Q8IZQ1 | |
| VSVSAVRTSFMVKMC | 1181 | Q2M1Z3 |